Article
San Francisco - In the United States surgery is the modality of choice for treatment of most primary as well as many recurrent lentigo maligna (LM), but there are a number of alternative options to consider for unresectable lesions, Glenn D. Goldman, M.D., said at the annual meeting of the American Academy of Dermatology.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.